How much funding has Core Biogenesis raised?

Core Biogenesis has raised $13.7M in total funding, most recently a Series A round.

Who are Core Biogenesis's investors?

Core Biogenesis's investors include XAnge, Blue Horizon Ventures, Thia Ventures, Entrepreneur First, Plug and Play.

When was Core Biogenesis founded?

Core Biogenesis was founded in 2020.

Where is Core Biogenesis headquartered?

Core Biogenesis is headquartered in Versailles, France.

What industry is Core Biogenesis in?

Core Biogenesis operates in Agtech, Biotech, Life Sciences.

How many employees does Core Biogenesis have?

Core Biogenesis has 11-50 employees.

Core Biogenesis

Biodesigning the future of regenerative medicine and longevity skincare

Versailles, France · Founded 2020 · $13.7M raised

Agtech

Biotech

Life Sciences

Headquarters: Versailles
Employees: 11–50
Founded: 2020
Business Model: B2B

Website: corebiogenesis.com
Total Funding: $13.7M
Last Round: $10.5M Series AJul 2022
Rounds: 2

About

Core Biogenesis is a Barcelona-based biotech company that uses plants as biofactories to produce high-value recombinant proteins and peptides for the life science and beauty and wellness industries. Its proprietary platform technology enables precise targeting of peptides and proteins to plant oleosomes, improving protein stability and enabling scalable, sustainable production. Applications include regenerative medicine, longevity skincare, and therapeutic protein supply for research and clinical use.

Summary

Core Biogenesis is an Agtech company based in Versailles, France, founded in 2020. It has raised $13.7M in total across 2 rounds, most recently a $10.5M Series A round in Jul 2022. Investors include XAnge, Blue Horizon Ventures and Thia Ventures.

LinkedIn X (Twitter)